Combination therapy for painful diabetic neuropathy is safe and effective.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 37085164.
- Also identified by DOI 10.1136/bmj.p866.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The studyTesfaye S, Sloan G, Petrie J, et al. Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial. <i>Lancet</i> 2022;400:680-90.To read the full NIHR Alert, go to: https://evidence.nihr.ac.uk/alert/combination-therapy-for-painful-diabetic-neuropathy-is-safe-and-effective/.
Medical subject headings
- Diabetic Neuropathies
- Diabetes Mellitus